Table 3. Stratified Analysis on the Association of the 2017 ACC/AHA Guideline Hypertension Categories on Cardiovascular Disease According to Subgroups of Antihypertensive Medication Prescription Within the First 5 Years of Follow-up.
Systolic/Diastolic Blood Pressure Measures, mm Hg | ||||
---|---|---|---|---|
Normal, <120/<80 mm Hg | Elevated, 120-129/<80 mm Hg | Hypertension | ||
Stage 1, 130-139/80-89 mm Hg | Stage 2, ≥140/≥90 mm Hg | |||
Men | ||||
Without antihypertensive medicationsa | ||||
Events | 6445 | 2580 | 11 275 | 4486 |
Person-years | 4 699 087 | 1 817 577 | 6 765 350 | 2 009 630 |
Incidence (events/100 000 person-years) | 137 | 142 | 167 | 223 |
Adjusted HR (95% CI)b | 1 [Reference] | 1.02 (0.98-1.07) | 1.17 (1.13-1.21) | 1.46 (1.41-1.52) |
With antihypertensive medicationsa | ||||
Events | 1688 | 862 | 4752 | 4172 |
Person-years | 257 384 | 119 185 | 673 465 | 567 160 |
Incidence (events/100 000 person-years) | 656 | 723 | 706 | 736 |
Adjusted HR (95% CI)b | 1 [Reference] | 1.08 (0.99-1.18) | 1.03 (0.97-1.09) | 1.03 (0.97-1.09) |
Women | ||||
Without antihypertensive medicationsa | ||||
Events | 3906 | 672 | 1914 | 408 |
Person-years | 4 818 403 | 704 185 | 1 806 338 | 246 289 |
Incidence (events/100 000 person-years) | 81 | 95 | 106 | 166 |
Adjusted HR (95% CI)b | 1 [Reference] | 1.08 (0.99-1.17) | 1.18 (1.12-1.25) | 1.51 (1.36-1.68) |
With antihypertensive medicationsa | ||||
Events | 577 | 158 | 585 | 333 |
Person-years | 112 833 | 26 986 | 104 168 | 54 721 |
Incidence (events/100 000 person-years) | 511 | 585 | 562 | 609 |
Adjusted HR (95% CI)b | 1 [Reference] | 1.10 (0.92-1.31) | 1.02 (0.90-1.14) | 1.04 (0.90-1.20) |
Abbreviation: ACC/AHA, American College of Cardiology and American Heart Association.
Antihypertensive medication prescription within the first 5 years of follow-up.
Hazard ratio calculated by Cox proportional hazards regression analysis after adjustments for age, household income, smoking, physical activity, alcohol consumption, body mass index, fasting serum glucose, total cholesterol, and Charlson comorbidity index.